Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of Automated Glucose Control With the Gen2 GlucoSTAT Bionic Pancreas in Volunteers With Type 1 and Type 2 Diabetes

NCT04227626 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04227626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04227626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of Automated Glucose Control With the Gen2 GlucoSTAT Bionic Pancreas in Volunteers With Type 1 and Type 2 Diabetes
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
April 30, 2021
Completion date
April 30, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes, type 2 diabetes treated with insulin